Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Betamethasone is more effective for hair regrowth than latanoprost but has more side effects.

Combining intradermotherapy with microneedling and a topical solution reduces hair loss more effectively than intradermotherapy alone.

New treatment using Minoxidil and EGCG with ionic liquids improves hair growth and quality for hair loss.

Combining minoxidil with MS injections leads to better hair regrowth in men.

A new treatment for hair loss uses tiny lipid carriers to deliver a mix of minoxidil and latanoprost directly to hair follicles, promoting hair growth and being well tolerated by the skin.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

Using minoxidil can cause severe skin reactions in some people.

Liposomes better deliver minoxidil for hair loss treatment than niosomes.

Oral minoxidil may improve hair loss in men and women, but has some side effects.

Minoxidil base is preferred for hair loss treatment, but minoxidil sulfate may be an alternative for unresponsive patients.

Scalp cooling is recommended to prevent chemotherapy-induced hair loss, but no effective drugs are available.

Objective assessment is needed to accurately determine medication use and adherence.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Some medications can cause acne, and stopping these drugs is the main treatment.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Lupus can affect the scalp and nails, often causing hair loss and nail damage, and needs early aggressive treatment to prevent permanent damage.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Niacin derivatives may increase hair fullness in women with hair loss.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.